JP2012527887A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527887A5
JP2012527887A5 JP2012512547A JP2012512547A JP2012527887A5 JP 2012527887 A5 JP2012527887 A5 JP 2012527887A5 JP 2012512547 A JP2012512547 A JP 2012512547A JP 2012512547 A JP2012512547 A JP 2012512547A JP 2012527887 A5 JP2012527887 A5 JP 2012527887A5
Authority
JP
Japan
Prior art keywords
gene
group
cells
clone
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012512547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012527887A (ja
JP5777113B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2010/003620 external-priority patent/WO2010137348A1/en
Publication of JP2012527887A publication Critical patent/JP2012527887A/ja
Publication of JP2012527887A5 publication Critical patent/JP2012527887A5/ja
Application granted granted Critical
Publication of JP5777113B2 publication Critical patent/JP5777113B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012512547A 2009-05-29 2010-05-28 人工多能性幹細胞のクローンの選択方法 Expired - Fee Related JP5777113B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21736209P 2009-05-29 2009-05-29
US61/217,362 2009-05-29
PCT/JP2010/003620 WO2010137348A1 (en) 2009-05-29 2010-05-28 Method for selecting clone of induced pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2012527887A JP2012527887A (ja) 2012-11-12
JP2012527887A5 true JP2012527887A5 (cg-RX-API-DMAC7.html) 2013-08-08
JP5777113B2 JP5777113B2 (ja) 2015-09-09

Family

ID=43222474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012512547A Expired - Fee Related JP5777113B2 (ja) 2009-05-29 2010-05-28 人工多能性幹細胞のクローンの選択方法

Country Status (4)

Country Link
US (1) US9005975B2 (cg-RX-API-DMAC7.html)
EP (1) EP2438159B1 (cg-RX-API-DMAC7.html)
JP (1) JP5777113B2 (cg-RX-API-DMAC7.html)
WO (1) WO2010137348A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5951254B2 (ja) 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
EP2321406B1 (en) * 2008-08-05 2014-12-10 Keio University Method for selecting secondary neurosphere derived from induced pluripotent stem cell
SG172160A1 (en) 2008-12-17 2011-07-28 Scripps Research Inst Generation and maintenance of stem cells
JP5682043B2 (ja) 2009-09-02 2015-03-11 国立大学法人京都大学 安全な多能性幹細胞の選択方法
MX389666B (es) * 2009-10-16 2025-03-19 Scripps Research Inst Induccion de celulas pluripotentes.
KR101775926B1 (ko) 2009-11-04 2017-09-07 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 화학 물질을 이용한 에피솜 재프로그래밍
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
WO2011158960A1 (en) 2010-06-15 2011-12-22 Kyoto University Method for selecting human induced pluripotent stem cells
US9732319B2 (en) 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
JP6143265B2 (ja) 2011-07-25 2017-06-07 国立大学法人京都大学 人工多能性幹細胞の選別方法
EP3095864B1 (en) * 2014-01-14 2020-04-15 Kagoshima University Method for labelling cancerization-causing cell in stem cells
CN120536341A (zh) 2014-03-04 2025-08-26 菲特治疗公司 改良的重编程方法和细胞培养平台
CN117737124A (zh) 2015-10-16 2024-03-22 菲特治疗公司 用于诱导和维护基态多能性的平台
JP7215994B2 (ja) 2016-09-06 2023-01-31 ザ チルドレンズ メディカル センター コーポレーション 人工多能性幹細胞由来の免疫細胞
KR101783977B1 (ko) 2016-12-30 2017-10-10 제일약품주식회사 기형종 형성이 억제된 전분화능 줄기세포 유래 신경 전구체구의 제조 방법
US11572544B2 (en) 2017-06-14 2023-02-07 The Children's Medical Center Corporation Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
KR20220130158A (ko) 2020-01-23 2022-09-26 더 칠드런스 메디칼 센터 코포레이션 인간 만능 줄기 세포로부터의 무-간질 t 세포 분화

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3660601B2 (ja) 2001-03-30 2005-06-15 独立行政法人科学技術振興機構 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法
AUPS225402A0 (en) 2002-05-10 2002-06-13 Bresagen Limited Modified cell production
WO2005080598A1 (ja) 2004-02-19 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. 体細胞核初期化物質のスクリーニング方法
AU2006304390A1 (en) 2005-10-17 2007-04-26 Academia Sinica Pulmonary stem cells, related methods and kits
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
KR100794362B1 (ko) 2006-02-27 2008-01-15 주식회사 임젠 Nanog를 이용한 아스트로사이트의 신경줄기세포로의역분화
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
EP2072618A1 (en) * 2007-12-14 2009-06-24 Johannes Gutenberg-Universität Mainz Use of RNA for reprogramming somatic cells
JP5951254B2 (ja) 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
EP2321406B1 (en) 2008-08-05 2014-12-10 Keio University Method for selecting secondary neurosphere derived from induced pluripotent stem cell
WO2011158960A1 (en) 2010-06-15 2011-12-22 Kyoto University Method for selecting human induced pluripotent stem cells

Similar Documents

Publication Publication Date Title
Comes et al. L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation
Orkin et al. Chromatin connections to pluripotency and cellular reprogramming
US10564167B2 (en) Method for detecting cells
WO2011135194A3 (en) Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes
RU2017100434A (ru) Набор или устройство для обнаружения рака молочной железы и способ обнаружения
CA2851316C (en) Genes and proteins for alkanoyl-coa synthesis
Beck et al. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression
JP2010158171A5 (cg-RX-API-DMAC7.html)
NZ704322A (en) Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EA201591411A1 (ru) Системы и способы для поддержки клинических решений
WO2011027310A8 (en) Novel tumor markers
WO2011122857A3 (ko) 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
CA2835730C (en) Molecular markers in prostate cancer
JP6143265B2 (ja) 人工多能性幹細胞の選別方法
NZ609567A (en) Markers of endothelial progenitor cells and uses thereof
WO2012032519A3 (en) Methods of diagnosing parkinson's disease
WO2009114673A3 (en) Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytes
Masuda et al. Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
WO2010082004A9 (fr) Procedes pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient et pour etablir un pronostic d'evolution d'un syndrome septique
WO2013093353A3 (fr) Procede pour le diagnostic ou le pronostic, in vitro, du cancer du poumon
WO2011027311A3 (en) Novel tumor markers
JP2014523736A5 (cg-RX-API-DMAC7.html)
JP5807879B2 (ja) 人工多能性幹細胞の選択方法
Adamo et al. LSD1 and pluripotency: a new player in the network
WO2013093315A3 (fr) Procede pour le diagnostic ou le pronostic, in vitro, du cancer du colon